schizandrin b has been researched along with gamma-aminobutyric acid in 1 studies
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
*gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system. [MeSH]
Studies (schizandrin b) | Trials (schizandrin b) | Recent Studies (post-2010) (schizandrin b) | Studies (gamma-aminobutyric acid) | Trials (gamma-aminobutyric acid) | Recent Studies (post-2010) (gamma-aminobutyric acid) |
---|---|---|---|---|---|
321 | 1 | 218 | 40,215 | 1,423 | 9,631 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Gao, J; Li, H; Li, N; Liu, J; Sun, J; Wang, C; Wang, M; Yu, Z; Zhu, K | 1 |
1 other study(ies) available for schizandrin b and gamma-aminobutyric acid
Article | Year |
---|---|
Sedative and hypnotic effects of Schisandrin B through increasing GABA/Glu ratio and upregulating the expression of GABA
Topics: Animals; Brain; Cyclooctanes; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Gene Expression; Glutamic Acid; Hypnotics and Sedatives; Lignans; Locomotion; Male; Mice; Mice, Inbred ICR; Polycyclic Compounds; Random Allocation; Rats; Rats, Wistar; Receptors, GABA-A; Up-Regulation | 2018 |